雷公藤多甙联合异甘草酸镁治疗儿童自身免疫性肝炎疗效及其对血清IL-17和CXCL10水平的影响

doi:10.3969/j.issn.1672-5069.2020.03.012

摘要/Abstract

摘要： 目的探讨应用雷公藤多甙联合异甘草酸镁治疗自身免疫性肝炎(AIH)儿童的疗效及对血清白介素-17(IL-17)和趋化因子10(CXCL10)水平的影响。方法 2018年1月~2019年3月我院儿科收治的AIH患儿57例,随机分为观察组29例和对照组28例。给予对照组异甘草酸镁注射液静脉滴注治疗,观察组在对照组治疗的基础上加用雷公藤多苷片口服治疗,两组均持续治疗8周。采用ELISA法检测血清IL-17、趋化因子8(CXCL8)和CXCL10水平。结果治疗后,观察组和对照组血清谷草转氨酶(AST)水平分别为(48.4±9.3)U/L和(61.2±12.5) U/L (P＜0.05)、丙氨酸氨基转移酶(ALT)水平分别为[(59.3±7.6)U/L和(66.4±9.7)U/L (P＜0.05)、碱性磷酸酶(ALP)水平分别为(60.2±5.1)U/L和(75.7±6.4)U/L(P＜0.05);两组血清免疫球蛋白G(IgG)水平分别为(13.8±2.9)mg/L和(16.3±3.4)mg/L(P＜0.05)、IgA水平分别为(2.4±0.3)mg/L和(2.9±0.5)mg/L(P＜0.05)、IgM水平分别为(2.6±0.3)mg/L和(3.1±0.4)mg/L (P＜0.05);血清IL-17水平分别为(6.8±0.7)ng/ml和(7.3±0.9)ng/ml (P＜0.05)、CXCL8水平分别为(10.4±1.2)pg/ml和(13.8±1.6) pg/ml (P＜0.05)、CXCL10水平分别为(16.3±2.5) pg/ml和(22.6±3.7)pg/m (P＜0.05);治疗后,观察组患儿不良反应发生率为12.5%,与对照组的7.5%比,差异无统计学意义(P＞0.05)。结论在异甘草酸镁治疗的基础上加用雷公藤多甙治疗儿童AIH疗效较好,安全性高,可有效改善肝功能和免疫功能,降低机体炎症反应,值得临床进一步验证。

关键词: 自身免疫性肝炎, 雷公藤多甙, 异甘草酸镁, 白介素-17, 趋化因子10, 治疗, 儿童 , ,

Abstract: Objective The aim of this study was to explore the efficacy of combination of tripterygium wilfordii polyglycosides and magnesium isoglycyrrhizinate in the treatment of children with autoimmune hepatitis (AIH) and its effect on serum interleukin--17 (IL-17) and chemokin10 (CXCL10) levels.Methods 57 children with AIH were enrolled in the Department of Pediatric in our hospital between January 2018 and March 2019, and were randomly divided into observation (n=29) and control group (n=28). The children in the control group were treated with magnesium isoglycyrrhizinate injection intravenously, while those in the observation group were treated with tripterygium wilfordii polyglycosides orally at the basis of treatment mentioned above. Serum IL-17, CXCL8 and CXCL10 levels were detected by ELISA. Results At the end of the regimen, serum AST levels in the observation and control groups were (48.4±9.3) U/L and (61.2±12.50) U/L (P<0.05), serum levels of alkaline phosphatase were (60.2±5.1) U/L and (75.7±6.4) U/L (P<0.05), and serum levels of alanine aminotransferase were (59.3±7.6) U/L and (66.4±9.7) U/L (P<0.05); serum levels of immunoglobulin G were (13.8±2.9) mg/L and (16.3±3.4) mg/L (P<0.05), serum levels of immunoglobulin A were (2.4±0.3) mg/L and (2.9±0.5) mg/L (P<0.05), and serum level of immunoglobulin M were (2.6±0.3) mg/L and (3.1±0.4) mg/L (P<0.05); serum levels of IL-17 were (6.8±0.7) ng/ml and (7.3±0.9) ng/ml (P<0.05), serum level of CXCL8 were (10.4±1.2) pg/ml and (13.8±1.6) pg/ml (P<0.05), and serum levels of CXCL10 were (16.3±2.5) pg/ml and (22.6±3.7) pg/m (P<0.05) between the two groups; during the treatment, the incidence of adverse reactions was 12.5% in the observation group and 7.5% in the control group (P>0.05). Conclusion The combination of tripterygium wilfordii polyglycosides and magnesium isoglycyrrhizinate in the treatment of children with AIH is efficacious and safe, which might improve liver function and immune function tests and reduce inflammatory reaction.

Key words: Autoimmune hepatitis, Tripterygium wilfordii polyglycosides, Magnesium isoglycyrrhizinate, Interleukin-17, Chemokine 10, Therapy, Children

杜颖,姜志红,吴雅玲. 雷公藤多甙联合异甘草酸镁治疗儿童自身免疫性肝炎疗效及其对血清IL-17和CXCL10水平的影响[J]. 实用肝脏病杂志, 2020, 23(3): 348-351.

Du Ying, Jiang Zhihong, Wu Yaling. Efficacy of tripterygium wilfordii polyglycosides and magnesium isoglycyrrhizinate combination in the treatment of children with autoimmune hepatitis[J]. Journal of Practical Hepatology, 2020, 23(3): 348-351.

参考文献

[1] 陈瑞玲, 王绮夏, 马雄. 自身免疫性肝炎精准医学的研究进展. 国际消化病杂志, 2019, 39(2):77-80, 95.
[2] Arcos-Machancoses JV, Molera Busoms C, Julio Tatis E, et al. Accuracy of the simplified criteria for autoimmune hepatitis in children: systematic review and decision analysis. J Clin Exp Hepatol, 2019, 9(2): 147-155.
[3] Nielsen J, Nerup N, Mller S, et al. Minimally invasive assessment of hepatic function in children with indocyanine green elimination: a validation study. Scand J Gastroenterol, 2019, 54(4): 485-491.
[4] 周炎仪, 阳灿. 雷公藤多甙联合异甘草酸镁治疗自身免疫性肝炎患者疗效初步研究. 实用肝脏病杂志, 2019, 22(3): 365-368.
[5] Violatto MB, Casarin E, Talamini L, et al. Dexamethasone conjugation to biodegradable avidin-nucleic-acid-nano-assemblies promotes selective liver targeting and improves therapeutic efficacy in an autoimmune hepatitis murine model. ACS Nano, 2019, 13(4): 4410-4423.
[6] Palle SK, Naik KB, McCracken CE, et al. Racial disparities in presentation and outcomes of paediatric autoimmune hepatitis. Liver Int, 2019, 39(5): 976-984.
[7] otowska JM, Sobaniec-otowska ME, Sobaniec P, et al. Liver sinusoidal endothelial cells in morphogenesis of pediatric autoimmune hepatitis. Pol J Pathol, 2018, 69(4): 327-334.
[8] Hanouneh M, Ritchie MM, Ascha M, et al. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis. Scand J Gastroenterol, 2019, 54(1): 76-80.
[9] Dillman JR, Serai SD, Trout AT, et al. Diagnostic performance of quantitative magnetic resonance imaging biomarkers for predicting portal hypertension in children and young adults with autoimmune liver disease. Pediatr Radiol, 2019, 49(3): 332-341.
[10] Nastasio S, Sciveres M, Matarazzo L, et al. Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine. Drugs, 2019, 79(1): 1-3.
[11] 朱吉, 王磊, 陈戈, 等. 健脾调肝方联合激素治疗自身免疫性肝炎的疗效及对肝功能的影响. 世界中医药, 2019, 14(5): 1282-1285.
[12] Mataya L, Patel N, Azzam RK. Autoimmune liver diseases in children. Pediatr Ann, 2018, 47(11): e452-e457.
[13] Li X, Sjstedt C, Sundquist J, et al. Familial association of attention-deficit hyperactivity disorder with autoimmune diseases in the population of Sweden. Psychiatr Genet, 2019, 29(2): 37-43.
[14] Bobrus-Chociej A, Flisiak-Jackiewicz M, Daniluk U, et al. Estimation of gamma-glutamyl transferase as a suitable simple biomarker of the cardiovascular risk in children with non-alcoholic fatty liver disease. Acta Biochim Pol, 2018, 65(4): 539-544.
[15] Jones D, Manns MP, Terracciano L, et al. Unmet needs and new models for future trials in autoimmune hepatitis. Lancet Gastroenterol Hepatol, 2018, 3(5): 363-370.
[16] Sood V, Lal BB, Rawat D, et al. Spectrum of pediatric autoimmune liver disease and validation of its diagnostic scores in indian children. J Pediatr Gastroenterol Nutr, 2018, 67(4): e65-e72.
[17] 孙孟宇, 刘文天. 调节性T细胞在自身免疫性肝病中的作用机理及治疗进展. 世界华人消化杂志, 2019, 27(11): 665-670.
[18] Kerkar N, Chan A. Hyperammonemic hepatic encephalopathy management through L-ornithin-L-aspartate administration in dogs. Clin Liver Dis, 2018, 22(4): 689-702.
[19] Grnbaek L, Vilstrup H, Jepsen P. Pregnancy and birth outcomes in a Danish nationwide cohort of women with autoimmune hepatitis and matched population controls. Aliment Pharmacol Ther, 2018, 48(6): 655-663.
[20] Xue R, Zhang H, Pan J, et al.Peripheral dopamine controlled by gut microbes inhibits invariant natural killer T cell-mediated hepatitis. Front Immunol, 2018,9:2398.